Study of Lenalidomide(Revlimid) Plus Rituximab (Revlirit Regimen) in Elderly Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma.
Phase of Trial: Phase II
Latest Information Update: 24 Aug 2012
At a glance
- Drugs Lenalidomide (Primary) ; Rituximab (Primary)
- Indications Diffuse large B cell lymphoma
- Focus Therapeutic Use
- 01 Dec 2011 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 06 Sep 2009 New trial record